Overview

Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection

Status:
Unknown status
Trial end date:
2011-04-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare and evaluate the efficacy of distilled water vs Mitomycin C on preventing the recurrences of intermediate risk group recurrent superficial bladder cancer administered as a single dose immediate instillation after complete Transurethral Resection(TUR) of the tumor.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Bozyaka Training and Research Hospital
Treatments:
Mitomycin
Mitomycins
Criteria
Inclusion Criteria:

- pathologic finding of superficial bladder cancer within the intermediate risk group

- recurred after 6 months from the primary tumor

- those patients who were included in our follow-up program since 2002 and whose records
could be obtained.

Exclusion Criteria:

- carcinoma in situ

- any form of intracavitary maintenance therapy

- any form of bladder cancer other than transitional cell type